Organon (OGN)

Organon (OGN) Stock Price & Analysis


OGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.87 - $36.43
Previous Close$19.76
Average Volume (3M)2.06M
Market Cap
Enterprise Value$13.29B
Total Cash (Recent Filing)$459.00M
Total Debt (Recent Filing)$8.71B
Price to Earnings (P/E)6.8
Aug 10, 2023
1.12 (5.55%)
Share Statistics
EPS (TTM)2.92
Shares Outstanding255,061,747
10 Day Avg. Volume2,608,586
30 Day Avg. Volume2,063,097
Standard Deviation0.12
Financial Highlights & Ratios
Price to Book (P/B)-0.83
Price to Sales (P/S)3.28
Price to Cash Flow (P/CF)10.90
P/FCF Ratio5.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.85
Enterprise Value/Gross Profit3.43
Enterprise Value/Ebitda10.13
Price Target Upside40.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Organon’s price range in the past 12 months?
Organon lowest stock price was $18.87 and its highest was $36.43 in the past 12 months.
    What is Organon’s market cap?
    Currently, no data Available
    When is Organon’s upcoming earnings report date?
    Organon’s upcoming earnings report date is Aug 10, 2023 which is in 65 days.
      How were Organon’s earnings last quarter?
      Organon released its earnings results on May 04, 2023. The company reported $1.08 earnings per share for the quarter, missing the consensus estimate of $1.166 by -$0.086.
        Is Organon overvalued?
        According to Wall Street analysts Organon’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Organon pay dividends?
          Organon pays a Quarterly dividend of $0.28 which represents an annual dividend yield of 5.67%. See more information on Organon dividends here
            What is Organon’s EPS estimate?
            Organon’s EPS estimate is $1.
              How many shares outstanding does Organon have?
              Organon has 255,061,750 shares outstanding.
                What happened to Organon’s price movement after its last earnings report?
                Organon reported an EPS of $1.08 in its last earnings report, missing expectations of $1.166. Following the earnings report the stock price went down -9.197%.
                  Which hedge fund is a major shareholder of Organon?
                  Among the largest hedge funds holding Organon’s share is Gotham Asset Management LLC. It holds Organon’s shares valued at 7M.


                    Organon Stock Smart Score

                    The Organon stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description


                    Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Its two operating segments are the Organon Products segment and the Merck Retained Products segment. It operates in the United States, China, Japan, Korea, and countries in Europe.


                    Top 5 ETFs holding OGN

                    Market Value
                    Smart Score
                    Vanguard S&P 500 ETF
                    SPDR S&P 500 ETF Trust
                    SPDR S&P 500 ETF Trust CDI
                    iShares Core S&P 500 ETF
                    Health Care Select Sector SPDR Fund
                    Up to five ETFs with an Outperform Smart Score that hold OGN. The ETFs are listed according to market value of OGN within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Bristol Myers
                    Royalty Pharma

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis